BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 11360182)

  • 1. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front.
    Paweletz CP; Charboneau L; Bichsel VE; Simone NL; Chen T; Gillespie JW; Emmert-Buck MR; Roth MJ; Petricoin III EF; Liotta LA
    Oncogene; 2001 Apr; 20(16):1981-9. PubMed ID: 11360182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells.
    Uzgare AR; Isaacs JT
    Cancer Res; 2004 Sep; 64(17):6190-9. PubMed ID: 15342404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer.
    Malik SN; Brattain M; Ghosh PM; Troyer DA; Prihoda T; Bedolla R; Kreisberg JI
    Clin Cancer Res; 2002 Apr; 8(4):1168-71. PubMed ID: 11948129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.
    Majumder PK; Febbo PG; Bikoff R; Berger R; Xue Q; McMahon LM; Manola J; Brugarolas J; McDonnell TJ; Golub TR; Loda M; Lane HA; Sellers WR
    Nat Med; 2004 Jun; 10(6):594-601. PubMed ID: 15156201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics.
    Dai B; Kong YY; Ye DW; Ma CG; Zhou X; Yao XD
    BJU Int; 2009 Oct; 104(7):1009-16. PubMed ID: 19389013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB.
    Van de Sande T; Roskams T; Lerut E; Joniau S; Van Poppel H; Verhoeven G; Swinnen JV
    J Pathol; 2005 Jun; 206(2):214-9. PubMed ID: 15880754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal pathway profiling of prostate cancer using reverse phase protein arrays.
    Grubb RL; Calvert VS; Wulkuhle JD; Paweletz CP; Linehan WM; Phillips JL; Chuaqui R; Valasco A; Gillespie J; Emmert-Buck M; Liotta LA; Petricoin EF
    Proteomics; 2003 Nov; 3(11):2142-6. PubMed ID: 14595813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer.
    Ropiquet F; Giri D; Kwabi-Addo B; Mansukhani A; Ittmann M
    Cancer Res; 2000 Aug; 60(15):4245-50. PubMed ID: 10945637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal prostate epithelial cells stimulate the migration of prostate cancer cells.
    Yu HM; Frank DE; Zhang J; You X; Carter WG; Knudsen BS
    Mol Carcinog; 2004 Oct; 41(2):85-97. PubMed ID: 15378647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation status of Fas-associated death domain-containing protein (FADD) is associated with prostate cancer progression.
    Shimada K; Matsuyoshi S; Nakamura M; Ishida E; Konishi N
    J Pathol; 2005 Aug; 206(4):423-32. PubMed ID: 15906275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy.
    Morote J; Fernández S; Alaña L; Iglesias C; Planas J; Reventós J; Ramón Y Cajal S; Paciucci R; de Torres IM
    Clin Cancer Res; 2008 May; 14(9):2617-22. PubMed ID: 18451224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence.
    Ayala G; Thompson T; Yang G; Frolov A; Li R; Scardino P; Ohori M; Wheeler T; Harper W
    Clin Cancer Res; 2004 Oct; 10(19):6572-8. PubMed ID: 15475446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention.
    Zeng L; Kyprianou N
    Prostate Cancer Prostatic Dis; 2005; 8(1):7-13. PubMed ID: 15477876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical examination of the mTORC1 pathway in high grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinomas (PCa): a tissue microarray study (TMA).
    Evren S; Dermen A; Lockwood G; Fleshner N; Sweet J
    Prostate; 2010 Sep; 70(13):1429-36. PubMed ID: 20687216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2.
    Moro L; Arbini AA; Yao JL; di Sant'Agnese PA; Marra E; Greco M
    Cell Death Differ; 2009 Apr; 16(4):571-83. PubMed ID: 19079138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of prostate stem cell antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Barbisan F; Mazzucchelli R; Santinelli A; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R
    Histopathology; 2010 Oct; 57(4):572-9. PubMed ID: 20955382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model.
    Diallo JS; Aldejmah A; Mouhim AF; Péant B; Fahmy MA; Koumakpayi IH; Sircar K; Bégin LR; Mes-Masson AM; Saad F
    Clin Cancer Res; 2007 Dec; 13(23):7044-52. PubMed ID: 18056181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.